The deadly trinity – COVID-19, hyperglycemia and mucormycosis release a cytokine cascade that delays IFN-γ release and puts the diabetic individual at a greater risk of developing endotheliitis and hence, mucormycosis in several organs like the heart, liver, and kidney [9]. This evidence concerns the gene IFNG and Zygomycosis.